{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:28:14Z","timestamp":1790681294667,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008091","name":"Golestan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jgar.2019.11.010","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T11:24:07Z","timestamp":1574508247000},"page":"380-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran"],"prefix":"10.1016","volume":"21","author":[{"given":"Fereshteh","family":"Ezadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailar","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naemeh","family":"Javid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdollah","family":"Ardebili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgar.2019.11.010_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2019.11.010_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fcimb.2017.00156","article-title":"Risk factors, clinical presentation, and outcome of Acinetobacter baumannii bacteremia","volume":"7","author":"Ballouz","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jgar.2019.11.010_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2019.11.010_bib0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2147\/IDR.S162232","article-title":"Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study","volume":"11","author":"Duszynska","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.jgar.2019.11.010_bib0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.sjbs.2016.02.009","article-title":"Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features","volume":"25","author":"Almasaudi","year":"2018","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"10.1016\/j.jgar.2019.11.010_bib0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2019.11.010_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.9.1.23","article-title":"Carbapenems: a potent class of antibiotics","volume":"9","author":"Nicolau","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"10.1016\/j.jgar.2019.11.010_bib0040","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-014-0267-8","article-title":"Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections","volume":"74","author":"Viehman","year":"2014","journal-title":"Drugs"},{"issue":"83","key":"10.1016\/j.jgar.2019.11.010_bib0045","first-page":"112","article-title":"Acinetobacter baumanniiDetermination of resistance pattern of isolated from hospitalized burned patients in Motahari Hospital, Tehran","volume":"20","author":"Ardebili","year":"2012","journal-title":"J Adv Med Biomed Res"},{"key":"10.1016\/j.jgar.2019.11.010_bib0050","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciy988","article-title":"Treatment outcomes of colistin-and carbapenem-resistant Acinetobacter baumannii infections: An exploratory subgroup analysis of a randomized clinical trial","volume":"69","author":"Dickstein","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2019.11.010_bib0055","first-page":"DC04","article-title":"Emergence of carbapenem resistant non-fermenting gram-negative bacilli isolated in an ICU of a tertiary care hospital","volume":"11","author":"Agarwal","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jgar.2019.11.010_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nmni.2018.08.007","article-title":"First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt","volume":"26","author":"Abdulzahra","year":"2018","journal-title":"New Microbes New Infect"},{"issue":"9","key":"10.1016\/j.jgar.2019.11.010_bib0065","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/cid\/civ048","article-title":"Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance","volume":"60","author":"Qureshi","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.11.010_bib0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jgar.2018.12.011","article-title":"Carbapenem-resistant Acinetobacter baumannii isolates carrying the blaOXA genes with an upstream ISAba1: The first report of a novel OXA subclass from Iran","volume":"18","author":"Yazdansetad","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"10.1016\/j.jgar.2019.11.010_bib0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jinf.2008.11.002","article-title":"Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme","volume":"58","author":"Yau","year":"2009","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.jgar.2019.11.010_bib0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1469-0691.2007.01912.x","article-title":"Heteroresistance: a concern of increasing clinical significance?","volume":"14","author":"Falagas","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jgar.2019.11.010_bib0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/AAC.00766-07","article-title":"Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy","volume":"52","author":"Hawley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jgar.2019.11.010_bib0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1099\/jmm.0.46816-0","article-title":"Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems","volume":"56","author":"Pournaras","year":"2007","journal-title":"J Med Microbiol"},{"issue":"4","key":"10.1016\/j.jgar.2019.11.010_bib0095","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jac\/dkr007","article-title":"Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae","volume":"66","author":"Meletis","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jgar.2019.11.010_bib0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.diagmicrobio.2009.05.019","article-title":"Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin","volume":"65","author":"Hernan","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.11.010_bib0105","series-title":"Performance standards for antimicrobial susceptibility testing; Twenty-seventh informational supplement. CLSI documet M100","author":"CLSI","year":"2017"},{"issue":"4","key":"10.1016\/j.jgar.2019.11.010_bib0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/0037-8682-0002-2016","article-title":"The role of the genetic elements bla oxa and IS Aba 1 in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in carbapenem resistance in the hospital setting","volume":"49","author":"Kobs","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"issue":"9","key":"10.1016\/j.jgar.2019.11.010_bib0115","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jgar.2019.11.010_bib0120","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1099\/jmm.0.059220-0","article-title":"Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and-resistant Pseudomonas aeruginosa","volume":"62","author":"Hermes","year":"2013","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.jgar.2019.11.010_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/sjmms.sjmms_138_16","article-title":"ERIC-PCR genotyping of Acinetobacter baumannii isolated from different clinical specimens","volume":"6","author":"Aljindan","year":"2018","journal-title":"Saudi J Med Med Sci"},{"key":"10.1016\/j.jgar.2019.11.010_bib0130","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/IDR.S166750","article-title":"Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities","volume":"11","author":"Asif","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"2","key":"10.1016\/j.jgar.2019.11.010_bib0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CMR.00117-13","article-title":"OXA \u03b2-lactamases","volume":"27","author":"Evans","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"10.1016\/j.jgar.2019.11.010_bib0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jiac.2018.02.009","article-title":"Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran","volume":"24","author":"Salehi","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2019.11.010_bib0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IDR.S182585","article-title":"In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran","volume":"12","author":"Kheshti","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"5","key":"10.1016\/j.jgar.2019.11.010_bib0150","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.3390\/molecules24050886","article-title":"In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii","volume":"24","author":"Oliva","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jgar.2019.11.010_bib0155","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01390-18","article-title":"Antimicrobial susceptibility testing for polymyxins: challenges, issues, and recommendations","volume":"57","author":"Ezadi","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jgar.2019.11.010_bib0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jac\/dkg468","article-title":"Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis","volume":"52","author":"Li","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jgar.2019.11.010_bib0165","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AAC.49.11.4814-4815.2005","article-title":"Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration","volume":"49","author":"Li","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.jgar.2019.11.010_bib0170","article-title":"Post neurosurgical meningitis due to colistin heteroresistant Acinetobacter baumannii","volume":"7","author":"Moosavian","year":"2014","journal-title":"Jundishapur J Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519303029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519303029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:57:26Z","timestamp":1761991046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519303029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":34,"alternative-id":["S2213716519303029"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.11.010","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}